Abstract: In this study the molecular foundation of nitric oxide induced relaxation of arteries, with or without endothelium, of normotensive and spontanously hypertensive rats was re-examined. With this purpose in mind, the effects of the nitric oxide donor sodium nitroprusside (NaNP), with and without manganese containing superoxide dismutase (MnSOD E.C. 1.15.1.1.), on rat renal artery relaxation was strudied. The results show that the relaxation effect of NaNP is two times higher in normotensive, compared to spontaneously hypertensive rats. Similar differences exist in the relaxation effects of NaNP on isolated renal arteries without endothelium, indicating that besides the difference in the function of an endothelium, concerning basal NO production in normotensive and hypertensive rats, there is a difference with respect to NO relaxation in the smooth muscle that is induced by hypertension. MnSOD decreased the relaxation effect of NaNP in all the examined renal arteries, more in normotensive than in hypertensive ones regardless of the presence of an endothelium. These results show that MnSOD, by modifying the chemical versatility of NO into redox active forms -nitrosonium (NO + ) and nitroxyl (NO -), produces different relaxation effects in normotensive and hypertensive arteries of rats, with or without an endothelium, potentiating the role of nitroxyl induced relaxation in sponteneously hypertensive rats. The results prove the need for the synthesis of complex NO donors, as the mechanisms of artery relaxation are different due to an endothel and smooth mouscle changes in hypertensive, as compared to normotensive rats.
INTRODUCTION
Endothelial dysfunction reduces endogenous bioactivity and identifies NO signaling as a key target for therapeutic intervention to preserve tissue integrity and minimize irreversible damage associate with hypertension and ischemic cardio-vascular diseases. 1 Diverse physiological and pathophysiological phenomena caused by nitric oxide (NO) are mediated through guanosine 3',5'-cyclic monophosphate (cGMP) dependent pathways or through cGMP-independent pathways, 2 NO signals, initiated by activation of guanilyl cyclase, are amplified by accumulated cGMP-propagated within cells by downstream effectors, primarily, GMP-dependent protein kinases, cyclic nucleotide-gated channels, and phosphodiesterases (PDEs). cGMP-dependent protein kinases, serine-threonine kinases, the activation of which is controlled by the binding of cGMP to allosteric regulatory domains, mediate smooth muscle relaxation by antagonizing the calcium required for contraction, reflecting inhibition of extracellular calcium influx and intracellular calcium release, and desensitization of the contractile apparatus to calcium. Other pathways are mediated through the formation of nitrosothiol adducts (RS-NOs). The proposed pathways for S-nitrosothiol (RSNOs) formation include the reaction of thiols with dinitrosyl-iron or nitrosylheme complexes or direct reaction of thiols with NO in presence of an electron acceptor, such as NAD + . 3 It was reported that the oxidative transformation of the free hydroxyl group of isosorbide-5-mononitrate (IS-5-MN) leads to the corresponding keto-nitrate of isosorbide, which was then converted to the isosorbide-5-nitrate-2-ketoxime. 4 The synthesized oximenitrate (10 -8 -10 -6 mol/L) also induces a concentration-dependent relaxation in a precontracted preparation of the superior mesenteric artery contracted by phenylephrine, but this inhibitory effect was statistically more intensive than that caused by IS-5-MN. It appears that the newly synthesized oxime nitrate is more effective as a vasodilating agent and it has been suggested that the new nitro compound could be of interest in the treatment of angina caused by coronary artery spasms. 5 In this study the effect of NO donors on relaxation of artery with respect to the chemical nature of NO donated was examined. One of these, sodium nitroprusside (NaNP) is an NO/NO + donor which is used clinically to treat hypertensive emergencies. 6 The mechanism of NO release from NaNP is still unknown. However, it is believed that in biological systems both enzymatic and nonenzymatic single-electron reductions may be involved. Another goal of this study was to investigate how the generation of nitrosonium (NO + ) and nitroxyl (NO -) ions, from NO liberated from NaNP in the presence of MnSOD, 3 influence the effect of NaNP.
EXPERIMENTAL
Experiments were performed on renal arteries isolated from male Wistar rats and spontaneously hypertensive (SH) rats, (250-300 g).
Adhering perivascular tissue was removed carefully from the arteries which were then cut into 3-5 mm rings, incubated 30 min in water bath in Krebs-Ringer bicarbonate solution at 36 ºC, and then gassed with 95 % O 2 and 5 % CO 2 . Each ring was gradually stretched to the optimal tension (2 g) and an isometric transducer registered the mechanical contractions.
Contractions of the isolated blood vessels were induced by phenylephrine (10 -6 mol) and the functional integrity of the endothelium was confirmed by acetylcholine (10 -5 mol) and hystopathologic examination. Preparations were analyzed using a microscope to distinguish differences between blood vessels of normotensive and hypertensive rats.
Blod vessels isolated from both normotensive and hypertensive rats were analyzed in three different situations: just isolated blood vessels; blood vessel contracted by phenylephrine; blood vessel relaxed (or not if the endothelium was not preserved) by acetylcholine. Hystopathological analysis (Figs. 1a and b) shows the endothelium was better preserved in normotensive than in hypertensive rats. The percentage relaxation caused by acetylcholine depended on the degree of endothelial preservation. In hypertensive rats the endothelium is spontaneously damaged due to high blood pressure, so the relaxing effect of acetylcholine is much lower than in normotensive rats.
Superoxide dismutase assay and isolation and purification
Sodium nitroprusside, acetylcholine, phenylephrine and all other chemicals were of reagent grade and were used without additional purification. MnSOD (Escherichia soli) was isolated according to Keele. 7 The activity of SOD was assayed by the adrenaline method. 8 
RESULTS AND DISCUSSION
The application of superoxide dismutases in medicine is based on their enzyme activity during which the superoxide anion radical (O 2 ·-) is removed. One important effect is protection against breakdown of the endothelium-derived vascular relaxation factor -nitric oxide (NO). 9 The pharmacological effects of various SODs have been examined 10 fects. The tested doses of L-SOD cause mutially a decrease of the blood pressure by 10-20 mmHg. Higher concentrations of liposomal Cu/Zn SOD cause a dose dependent relaxation of isolated inferior mesenteric arteries after contraction by use of phenylephrine. 11 Free Cu/Zn SOD doses tested in terms of blood pressure caused a three-phase effect, 11 which may be explained by a mechanism in which SOD supports a reversible reduction of NO -to NO, 12 in addition to O 2 ·-scavenging. The generation of nitrosonium (NO + ) and nitroxyl (NO -) ions in NO treated MnSOD, leading to enzyme modifications and inactivation, was demonstrated. 3 The nitroxyl anion (NO -) is a redox sensitive positive inotrope with selective vasodilating action 13 and the different chemical behavior of NO and NO -toward hem proteins offers a unique control mechanism for the biological action of NO. 14 The influence of MnSOD (E. coli) on the relaxing effect of sodium nitroprusside (NaNP) on the isolated renal artery of normotensive rats with/without an endothelium was examined and the results are presented at Fig. 2 and Fig. 3 .
The results show that MnSOD antagonizes the relaxation effect of NaNP independently of the presence of an endothelium and of the MnSOD concentration. As can be calculated from Fig. 5 , MnSOD antagonizes the relaxation effect of NaNP by 130-240 %, indicating that the transformation of NO into nitroxyl anions leads to a diminished relaxation.
As shown in Figs. 4 and 5, the inhibitory effect of MnSOD on the relaxation induced by NaNP is less expressed in spontaneously hypertensive rats. The influence of sGC (via reduced production and/or activity of basal nitric oxide) on the cerebral vascular tone is reduced in atherosclerosis. 15 The differential chemical behavior of NO and HNO toward heme proteins provides insight into mechanisms then relaxed with acetylcholine -Ach (10 -5 M) and after washing another concentration was induced with Pe (10 -6 M) and treated with increasing concentrations of sodium nitroprussideNaNP (10 -10 M, 10 -9 M, 10 -8 M, 10 -6 M and 10 -5 M). After washing, the same protocols were repeated in the presence of different concentrations of MnSOD (0.1 mg/ml; 1 mg/ml; 10 mg/ml and 100 mg/ml) in the medium.
which helps to explain some of the opposing effects of SODs observed in NOS-mediated events. Nitroxyl anions liberate the 37 amino acid peptide, a calcitonine gene related peptide (CGRP), which is the most potent vasodilatator known to date and is thought to be involved in the regulation of resting blood pressure and regional blood flow in vivo. In patents suffering from heart failure (HF), CGRP has been shown to reduce pulmonary and systemic pressure and to increase cardiac performance without producing tachycardia. 16 A possible explanation of our results may be that MnSOD eliminates NO and reduces cGMP dependent relaxation.
RELAXATION OF ARTERIES 977 Fig. 3 . A representative trace of the responses of an isolated renal artery from a normotensive rat without an endothelium (E-). The renal artery was precontracted with phenylephrine -Pe (10 -6 M) then relaxed with acetylcholine -Ach (10 -5 M) and after washing another contraction was induced with Pe (10 -6 M) and treated with increasing concentrations of sodium nitroprussideNaNP (10 -10 M, 10 -9 M, 10 -8 M, 10 -6 M and 10 -5 M). After washing the same protocols were repeated in the presence of different concentrations of MnSOD (0.1 mg/ml; 1 mg/ml; 10 mg/ml and 100 mg/ml) in the medium. Fig. 4 . A representative trace of the responses of an isolated renal artery from a hypertensive rat with an endothelium (E+). The renal artery was precontracted with phenylephrine -Pe (10 -6 M) then relaxed with acetylcholine -Ach (10 -5 M) and after washing another contraction induced with Pe (10 -6 M) and treated with increasing concentrations of sodium nitroprusside -NaNP (10 -10 M, 10 -9 M, 10 -8 M, 10 -6 M and 10 -5 M). After washing the same protocols were repeated in the presence of different concentrations of MnSOD (0.1 mg/ml; 1 mg/ml; 10 mg/ml and 100 mg/ml) in the medium.
Another mechanism, none cGMP dependent, is that nitroxyl anion mediated relaxation may be operative in vivo. It seems that this is more expressed in spontaneously hypertensive than in normotensive rats, indicating that vascular dysfunction in spontaneously hypertensive rats is not solely endothelial -derived but involve other componenets, such as the vascular smooth muscle.
CONCLUSION
The presented results show a two times higher relaxation effect of NaNP in normotensive, compared to spontaneously hypertensive rats. Similar differences exist in the relaxation effects of NaNP on isolated renal arteries without an endothelium, indicating that besides the difference in the function of endothelium, concerning basal NO production in normotensive and hypertensive rats, there is a difference in the smooth muscle that is induced by hypertension with respect to NO relaxation. The presence of MnSOD decreases the relaxation effect of NaNP in all the examined renal arteries, more in normotensive than in hypertensive ones, regardless of the presence of an endothelium. These results show that MnSOD, by modifing chemical versatility of NO into redox active forms -nitrosonium (NO +) and nytroxyl (NO -), produces different relaxation effects in the arteries of normotensive and hypertensive rats with or without an endothelium, potentiating the possible role of nitroxyl induced relaxation in spontaneously hypertensive rats. Fig. 5 . A representative trace of the responses of an isolated renal artery from a hypertensive rat without endothelium (E-). The renal artery was precontracted with phenylephrine -Pe (10 -6 M) and then relaxed with acetylcholine -Ach (10 -5 M) and after washing another contraction was induced with Pe (10 -6 M) and treated with increasing concentrations of sodium nitroprussideNaNP (10 -10 M, 10 -9 M, 10 -8 M, 10 -6 M and 10 -5 M). After washing the same protocols were repeated in the presence of different concentrations of MnSOD (0.1 mg/ml; 1 mg/ml; 10 mg/ml and 100 mg/ml) in the medium.
U ovom radu smo poku{ali da detaqnije ispitamo molekulsku osnovu azotoksid indukovane relaksacije arterija, sa i bez endotela, normotenzivnih i spontano hipertenzivnih pacova. U tu svrhu ispitivan je efekat azot-oksid (NO) donora natrijum-nitroprusida (NaNP), bez i u prisustvu superoksid-dismutaze koja sadr`i mangan (MnSOD, EC 1.15.1.1.) na relaksaciju renalne arterije. Rezulati pokazuju dvostruko ve}i relaksantni efekat NaNP kod normotenzivnih, u odnosu na spontano hipertenzivne pacove. Sli~na razlika postoji i u relaksantnom efektu NaNP na izolovane renalne arterije normotenzivnog i hipertenzivnog pacova kada je odstrawen endotel {to ukazuje da, pored razlike u funciji endotela u odnosu na bazalnu NO produkciju kod normotenzivnih i spontano hipertenzivnih pacova, postoje i promene u glatkim mi{i}ima indukovane hipertenzijom, u odnosu na NO relaksaciju. MnSOD kod svih grupa smawuje relaksantni efekat SNP i to vi{e kod normotenzivnih nego kod hipertenzivnih, nezavisno od prisustva endotela. Ovi rezultati pokazuju da MnSOD mewaju}i hemijsku prirodu iz NaNP oslobo|enog NO u redoks aktivne forme -nitrozonijum (NO + ) i nitroksil (NO -) -ostvaruje razli~it relaksantni efekat kod normotenzivnih i kod hiperetenzivnih pacova sa i bez endotela potenciraju}i zna~aj nitroksilom indukovane relaksacije kod spontano-hipertenzivnih pacova. Dobijeni rezultati potvr|uju potrebu sinteze NO donora koji daju razli~ite redoks-aktivne forme NO budu}i da se primarni mehanismi relaksacije razlikuju u zavisnosti od karakteristika endotela i glatkih mi{i}a, kod hipertenzije u odnosu na normotenzivno stawe. (Primqeno 20. maja 2004) 
